IHE vs. CNCR ETF Comparison

Comparison of iShares U.S. Pharmaceutical ETF (IHE) to Loncar Cancer Immunotherapy ETF (CNCR)
IHE

iShares U.S. Pharmaceutical ETF

IHE Description

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$67.45

Average Daily Volume

33,474

Number of Holdings *

10

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.22

Average Daily Volume

3,744

Number of Holdings *

67

* may have additional holdings in another (foreign) market
Performance
Period IHE CNCR
30 Days -4.95% -13.14%
60 Days -5.48% -15.74%
90 Days -5.48% -11.75%
12 Months 17.51% 25.96%
2 Overlapping Holdings
Symbol Grade Weight in IHE Weight in CNCR Overlap
BMY B 5.27% 1.72% 1.72%
MRK D 4.09% 1.24% 1.24%
IHE Overweight 8 Positions Relative to CNCR
Symbol Grade Weight
JNJ C 22.25%
LLY F 20.67%
VTRS B 4.69%
PFE F 4.38%
ZTS D 4.32%
CTLT C 4.23%
RPRX D 4.18%
ITCI C 3.33%
IHE Underweight 65 Positions Relative to CNCR
Symbol Grade Weight
GLUE C -2.03%
EXEL B -1.9%
RVMD C -1.84%
ACLX C -1.73%
ELVN D -1.68%
XNCR B -1.66%
MRSN D -1.62%
BPMC B -1.58%
KPTI D -1.57%
REPL D -1.56%
GNLX F -1.56%
MGNX F -1.55%
HCM D -1.54%
SWTX C -1.47%
CRBU D -1.47%
JANX C -1.46%
ERAS C -1.46%
DAWN D -1.44%
IMCR D -1.42%
RXRX F -1.39%
SDGR C -1.39%
ARVN F -1.39%
AURA D -1.38%
LYEL F -1.35%
SNDX F -1.34%
MRUS F -1.33%
KYMR D -1.32%
RPTX F -1.32%
GERN D -1.31%
IOVA F -1.3%
RCUS F -1.29%
NRIX C -1.29%
FHTX C -1.26%
NUVB C -1.26%
BNTX C -1.25%
ZNTL F -1.25%
BCYC F -1.24%
YMAB F -1.24%
BMEA F -1.22%
PGEN F -1.2%
CGEM F -1.2%
ALLO F -1.18%
NUVL C -1.18%
VOR D -1.17%
GMAB F -1.17%
TYRA F -1.16%
KURA F -1.16%
ACRV F -1.15%
AUTL F -1.13%
STRO F -1.12%
LEGN D -1.1%
IDYA F -1.07%
TSVT F -1.06%
REGN F -1.0%
ITOS F -0.98%
IPHA D -0.98%
SMMT D -0.97%
ACET F -0.97%
IMRX F -0.95%
IMTX F -0.93%
RLAY F -0.91%
IGMS F -0.88%
RAPT F -0.88%
FATE F -0.87%
PRLD F -0.55%
Compare ETFs